Many Diabetic Patients are Taking Their Meds Only Short-Term
Many Diabetic Patients are Taking Their Meds Only Short-Term
The scope of the diabetes problem in the United States and around the world is truly hard to comprehend. As an inevitable side effect of the obesity epidemic that has been going on for years, cases of type 2 diabetes have skyrocketed in recent years, as have attempts to develop drugs that will combat the disease. Unfortunately, not all of these drugs wind up meeting the expectations of diabetic patients, as a recent study has found.The categories of drugs that are often known as second line therapies in the fight against type 2 diabetes includes brand names such as Ozempic and Mounjaro. These names are well-known to the general public via their aggressive ad campaigns, which speaks to just how much demand exists for care for diabetic patients.In many cases, patients are moved to these drugs because they aren’t getting the desired results from metformin, which is a long-standing player in this space. While these types of drugs can lead to effective outcomes, it’s the side effects that they deliver that are making them hard to use for many people.
Photo by Artem Podrez from Pexels
Sources:
Many patients with diabetes quit Ozempic, Mounjaro within a yearNational Diabetes Statistics Report
Nearly 40% of Type 2 diabetes patients stop taking their second-line medication
About Sara E. Teller
Sara is a credited freelance writer, editor, contributor, and essayist, as well as a novelist and poet with nearly twenty years of experience. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She has an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling, graduating with a 4.2/4.0 GPA. She is also a member of Chi Sigma Iota and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her fifth book, PTSD: Healing from the Inside Out, was released in September 2019 and is available on Amazon. You can find her others books there, too, including Narcissistic Abuse: A Survival Guide, released in December 2017.